Stock LXS LANXESS AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials LANXESS AG

Equities

LXS

DE0005470405

Diversified Chemicals

Market Closed - Xetra
Other stock markets
 11:35:03 2024-04-26 am EDT 		5-day change 1st Jan Change
25.77 EUR +0.04% Intraday chart for LANXESS AG -0.31% -9.16%
Apr. 26 LANXESS AG : Barclays reiterates its Neutral rating ZD
Apr. 19 LANXESS AG : Berenberg reiterates its Buy rating ZD

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,231 5,419 4,701 3,255 2,450 2,225 - -
Enterprise Value (EV) 1 6,973 6,431 6,946 7,069 2,450 4,795 4,628 4,435
P/E ratio 25.8 x 6.14 x 17.6 x 17.7 x 5.53 x -11.7 x 109 x 19.4 x
Yield 1.59% 1.59% 1.93% 2.79% - 0.4% 2.01% 1.66%
Capitalization / Revenue 0.73 x 0.89 x 0.62 x 0.4 x 0.36 x 0.34 x 0.32 x 0.31 x
EV / Revenue 0.98 x 1.05 x 0.92 x 0.87 x 0.36 x 0.73 x 0.66 x 0.62 x
EV / EBITDA 6.84 x 7.46 x 6.88 x 7.6 x 4.78 x 8.52 x 6.16 x 5.37 x
EV / FCF 51.7 x 49.9 x -174 x -28.5 x - 24.5 x 23.3 x 15.9 x
FCF Yield 1.94% 2.01% -0.58% -3.51% - 4.09% 4.3% 6.3%
Price to Book 2 x 1.83 x 1.25 x 0.74 x - 0.52 x 0.52 x 0.51 x
Nbr of stocks (in thousands) 87,448 86,346 86,258 86,346 86,346 86,346 - -
Reference price 2 59.82 62.76 54.50 37.70 28.37 25.77 25.77 25.77
Announcement Date 3/11/20 3/11/21 3/11/22 3/15/23 3/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,131 6,104 7,557 8,088 6,714 6,611 6,970 7,204
EBITDA 1 1,019 862 1,010 930 512 563 751.2 826.5
EBIT 1 557 396 500 389 -53 19.06 211.2 296.5
Operating Margin 7.81% 6.49% 6.62% 4.81% -0.79% 0.29% 3.03% 4.12%
Earnings before Tax (EBT) 1 346 1,074 303 257 -947 -197.3 66.79 172.9
Net income 1 205 885 267 250 443 -226.4 21.99 107.7
Net margin 2.87% 14.5% 3.53% 3.09% 6.6% -3.42% 0.32% 1.5%
EPS 2 2.320 10.22 3.090 2.130 5.130 -2.200 0.2370 1.330
Free Cash Flow 1 135 129 -40 -248 - 196 199 279.3
FCF margin 1.89% 2.11% -0.53% -3.07% - 2.96% 2.86% 3.88%
FCF Conversion (EBITDA) 13.25% 14.97% - - - 34.81% 26.49% 33.8%
FCF Conversion (Net income) 65.85% 14.58% - - - - 904.82% 259.27%
Dividend per Share 2 0.9500 1.000 1.050 1.050 - 0.1022 0.5188 0.4267
Announcement Date 3/11/20 3/11/21 3/11/22 3/15/23 3/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 3,140 1,951 2,082 2,432 1,999 3,930 2,185 1,973 1,899 1,778 1,601 1,436 1,528 1,703 1,774 1,651 1,601
EBITDA 1 - 278 213 320 253 515 240 175 189 107 119 97 93.74 129.7 169 171.7 160.9
EBIT 1 165 146 72 182 122 260 101 28 53 -29 -22 -55 -35.52 -3.675 35.47 40.55 22.22
Operating Margin 5.25% 7.48% 3.46% 7.48% 6.1% 6.62% 4.62% 1.42% 2.79% -1.63% -1.37% -3.83% -2.32% -0.22% 2% 2.46% 1.39%
Earnings before Tax (EBT) 1 - 94 16 - 67 - 120 -21 13 -157 -142 -661 -87 -42 -25 -43 -
Net income 1 - 74 29 98 93 - 80 -21 -44 1,371 -131 -753 -92.5 -43 -26 -44 -
Net margin - 3.79% 1.39% 4.03% 4.65% - 3.66% -1.06% -2.32% 77.11% -8.18% -52.44% -6.05% -2.52% -1.47% -2.66% -
EPS 2 9.930 0.8600 0.3400 1.130 1.080 2.210 0.9300 -0.1600 -0.5100 15.88 -1.520 -8.720 -1.120 - - - -
Dividend per Share 2 - - 1.050 - - - - 1.050 - - - - - - - 0.1200 -
Announcement Date 8/13/20 11/4/21 3/11/22 5/5/22 8/4/22 8/4/22 11/9/22 3/15/23 5/10/23 8/4/23 11/8/23 3/14/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,742 1,012 2,245 3,814 - 2,569 2,402 2,209
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.71 x 1.174 x 2.223 x 4.101 x - 4.564 x 3.198 x 2.673 x
Free Cash Flow 1 135 129 -40 -248 - 196 199 279
ROE (net income / shareholders' equity) 7.52% 31.2% 7.9% 6.11% - -2.52% 2.77% 4.83%
ROA (Net income/ Total Assets) 2.36% 10.1% 2.75% 2.29% - -2.07% 0.05% 1.22%
Assets 1 8,691 8,788 9,699 10,905 - 10,913 44,084 8,816
Book Value Per Share 2 30.00 34.30 43.50 51.20 - 49.40 49.40 50.50
Cash Flow per Share 2 7.280 6.760 4.710 1.350 - 4.790 5.650 5.260
Capex 1 508 456 479 407 - 349 378 395
Capex / Sales 7.12% 7.47% 6.34% 5.03% - 5.28% 5.42% 5.48%
Announcement Date 3/11/20 3/11/21 3/11/22 3/15/23 3/14/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for LANXESS AG

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
25.77 EUR
Average target price
28.15 EUR
Spread / Average Target
+9.23%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

1st Jan change Capi.
LANXESS AG Stock LANXESS AG
-9.16% 2.38B
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
-0.19% 80.96B
BASF SE Stock BASF SE
+0.09% 48.75B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
-4.19% 30.73B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+9.85% 17.82B
BRENNTAG SE Stock Brenntag SE
-10.05% 11.7B
SYENSQO SA/NV Stock Syensqo SA/NV
-8.09% 9.65B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
+2.79% 9.52B
SRF LIMITED Stock SRF Limited
+6.35% 9.39B
MITSUBISHI CHEMICAL GROUP CORPORATION Stock Mitsubishi Chemical Group Corporation
+3.85% 8.2B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. LXS Stock
  4. Financials LANXESS AG